Zobrazeno 1 - 10
of 43
pro vyhledávání: '"M D, Pescovitz"'
Autor:
A, Humar, A, Asberg, D, Kumar, A, Hartmann, G, Moussa, A, Jardine, H, Rollag, H, Mouas, C G, Gahlemann, M D, Pescovitz, Michael, Zakliczynsk
Publikováno v:
American Journal of Transplantation. 9:374-381
The effect of herpesvirus co-infections (HHV-6, HHV-7) on cytomegalovirus (CMV) disease and its response to therapy is unknown. We prospectively analyzed herpesvirus co-infections in transplant recipients with CMV disease. All patients received 3 wee
Autor:
R. Ferguson, Mark H. Deierhoi, Thomas A. Gonwa, E. Hodge, S. Cho, S. Weinstein, C. Johnson, Donald A. Norman, S. Tomlanovich, J. L. Neylan, H. W. Sollinger, M. M. Rees, E. Ramos, G. Danovitch, M. D. Pescovitz, W. Wang, Joshua Miller
Publikováno v:
American Journal of Kidney Diseases. 34:296-303
Autor:
M D, Pescovitz, R B, Ettenger, C F, Strife, J R, Sherbotie, S E, Thomas, S, McDiarmid, S, Bartosh, J, Ives, M R, Bouw, J, Bucuvalas
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 12(3)
In an open-label, prospective, pharmacokinetic assessment, we evaluated total drug exposure (area under the curve [AUC]) of intravenous (IV) ganciclovir (GCV) and oral (p.o.) valganciclovir when normalized for body surface area (BSA) in pediatric liv
Autor:
R. S. Filo, S. B. Leapman, L. Lumeng, M. D. Pescovitz, M. H. Kabeer, Rahul M. Jindal, M. L. Milgrom
Publikováno v:
Postgraduate Medical Journal. 71:239-241
Central pontine myelinolysis can occur after orthotopic liver transplantation leading to high mortality and serious morbidity. In our case, central pontine myelinolysis was associated with wide fluctuations in cyclosporine levels during an episode of
Autor:
G L, Bumgardner, I, Hardie, R W, Johnson, A, Lin, B, Nashan, M D, Pescovitz, E, Ramos, F, Vincenti
Publikováno v:
Transplantation. 72(5)
Daclizumab (Zenapax, Roche Pharmaceuticals), a humanized monoclonal antibody directed against the alpha chain of the interleukin 2 receptor, has been shown to reduce the incidence of acute rejection at 6 months after renal transplantation in two phas
Autor:
J M, Kovarik, M D, Pescovitz, H W, Sollinger, B, Kaplan, C, Legendre, K, Salmela, B K, Book, C, Gerbeau, D, Girault, K, Somberg
Publikováno v:
Clinical transplantation. 15(2)
Pharmacokinetic sampling was performed in two multicenter trials in which basiliximab (anti-CD25 monoclonal antibody) was administered with triple immunosuppression consisting of cyclosporine microemulsion, corticosteroids, and either azathioprine or
Publikováno v:
Transplantation. 68(10)
The novel agent sirolimus (SRL; Rapamune; rapamycin) inhibits the immune response by a mechanism distinct from those of calcineurin antagonists or antimetabolites. This randomized, controlled, multicenter, single blind, phase II trial examined the co
Publikováno v:
Transplantation. 68(2)
Daclizumab is a newly developed humanized anti-IL-2 receptor monoclonal antibody. We describe the effect of adding daclizumab to conventional dual or triple cyclosporine A immunosuppressive therapy on the incidence and nature of cytomegalovirus (CMV)
Autor:
L K, Dalla Vecchia, B K, Book, M L, Milgrom, R M, Jindal, S B, Leapman, R S, Filo, M D, Pescovitz
Publikováno v:
Transplantation. 64(12)
Measurement of panel-reactive antibody (PRA) with an enzyme-linked immunosorbent assay using soluble HLA class I molecules (PRA-STAT) in adult renal transplant recipients predicted graft loss and rejection. We sought to confirm this finding in pediat
Publikováno v:
Clinical transplantation. 11(6)
An oral formulation of ganciclovir (GAN) has been shown to be effective as prophylaxis of cytomegalovirus (CMV) after liver transplantation in an adult population. There are no data on the use or dose of oral GAN in pediatric transplant recipients. W